FDA approves new pill to lower cholesterol

The FDA has given the green light to Merck's Lipfendra, a new daily pill that lowers cholesterol by working differently from statins. As a PCSK9 inhibitor, it's a significant shift from the previously injectable forms of this medication, offering patients an easier and more convenient option. This approval could revolutionize cholesterol management, especially for those who find injections cumbersome. It's a big deal because effective, accessible cholesterol treatments are crucial for preventing heart disease, which remains a leading cause of death worldwide.